Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01032057
What this trial is testing

Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Lisette Nixon 114
Not applicableEnded earlyNCT03073473
What this trial is testing

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more
Cota Inc. 40
Not applicableLooking for participantsNCT07326137
What this trial is testing

A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

Who this might be right for
Advanced Biliary Tract Cancer(BTC)Advanced Pancreatic CancersCancer-related Pain
Tongji Hospital 103
Not applicableLooking for participantsNCT05403177
What this trial is testing

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Who this might be right for
Breast CancerColorectal CancerPancreas Cancer+9 more
University Health Network, Toronto 500
Not applicableLooking for participantsNCT04282083
What this trial is testing

Protocol ITANET - Registry

Who this might be right for
Gastro-entero Pancreatic Neuroendocrine Tumors
Italian Association Neuroendocrine Tumors 3,600
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableStudy completedNCT06129812
What this trial is testing

An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerNeoadjuvant
Seoul National University Hospital 1,132
Not applicableStudy completedNCT05470166
What this trial is testing

Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

Who this might be right for
ERASLidocaineCancer of Pancreas+1 more
Alexandria University 30
Not applicableUnknownNCT04783831
What this trial is testing

Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy

Who this might be right for
Pancreatic FistulaPancreas NeoplasmStent Disintegration+2 more
Hospital Universitario Virgen de la Arrixaca 60
Early research (Phase 1)Study completedNCT00352131
What this trial is testing

Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors

Who this might be right for
Non-colorectal CancerPancreatic Cancer
ImmunoGen, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00042939
What this trial is testing

Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group 94
Not applicableEnded earlyNCT04311047
What this trial is testing

Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI

Who this might be right for
Pancreatic CancerPeriampullary Cancer
Radboud University Medical Center 26
Not applicableUnknownNCT01127815
What this trial is testing

Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Taiwan University Hospital 300
Not applicableStudy completedNCT05547074
What this trial is testing

A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma

Who this might be right for
Neoplasms Pancreatic
Zhejiang University 302
Testing effectiveness (Phase 2)Looking for participantsNCT07539155
What this trial is testing

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Who this might be right for
Borderline Resectable/Unresectable Pancreatic CancerNon Metastatic Pancreatic Cancer
University of Arkansas 20
Post-approval studies (Phase 4)Active Not RecruitingNCT05634720
What this trial is testing

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Duke University 20
Early research (Phase 1)Looking for participantsNCT06639724
What this trial is testing

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of California, San Diego 36
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Next Page